NCT03204448View on ClinicalTrials.gov

Clinical Performance of BioCLIA Ro60

WithdrawnOBSERVATIONAL

0

Timeline

Start Date

May 8, 2017

Primary Completion Date

April 16, 2020

Study Completion Date

April 16, 2020

Conditions

Systemic Lupus ErythematosusSjogren's Syndrome

Interventions

DEVICE

BioCLIA Ro60

BioCLIA Ro60 is a Chemiluminescent Immuno Assay (CLIA) as a fully automated testing process, reporting with arbitrary units, RU/mL

Trial Locations (1)

92618

CRM Biotech, Irvine

Sponsors

Lead Sponsor

HOB Biotech Group

All Listed Sponsors

lead

HOB Biotech Group

INDUSTRY

NCT03204448 - Clinical Performance of BioCLIA Ro60 | Biotech Hunter | Biotech Hunter